home > services > triResolve > triResolve QuickPort
triResolve - portfolio reconciliation & counterparty exposure management service
triResolve QuickPort

quick and easy portfolio data delivery


New regulations require regular reconciliation of all OTC derivative portfolios. With triResolve QuickPort, TriOptima now offers a safe and effective way for non-subscribers to respond to portfolio requests from OTC derivatives counterparties at no cost.

Designed to eliminate email and other unsecure means of portfolio delivery to multiple counterparties, data is uploaded to the secure triResolve QuickPort site manually or via automated file transfer for reconciliation.  triResolve QuickPort delivers a summary of the results, indicating where differences exist with counterparties.

triResolve QuickPort is offered free of charge upon signing a mutual Non-Disclosure Agreement with TriOptima.

triResolve vs. triResolve QuickPort
While triResolve QuickPort offers a secure and efficient way to upload portfolios and view summary reconciliation results, regular subscribers to the triResolve exposure management service enjoy the full range of service benefits.

     triResolve    triResolve QuickPort
Portfolio Delivery    
Leverage existing file formats
Low-touch IT involvement
Single point portfolio submission to counterparties
Secure portfolio submission to counterparties
Proactive Portfolio Reconciliation    
Immediate online access to network community
Real-time view of unresolved exceptions
Smart matching for portfolio reconciliation
Resolve discrepancies via exception management workflow
Repository Validation and Reconciliation    
Validate and reconcile internal books and records against repository data
Reconcile across trade repositories without the need for a UTI/USI
Highlights differences across all reported fields 
Dispute Resolution    
Identify & investigate sources of disputes
Monitor dispute resolution process / send notifications
Summary report of reconciliation results
Advanced analytics and fully flexible MI reporting


downloads icon
Insight providers: Mary Harris, Business Manager triResolve and Susan Hinko, Head of Industry Relations, TriOptima The new year brings with it an onslaught of requirements for managing OTC derivative portfolios, cleared and

Please enter your full name.

Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use

1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.

2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.

    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.

3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.

    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.

4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.

    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.

    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.

    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.

    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.

    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.

5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.

6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline

We use cookies to ensure that you get the best possible experience of our website. By continuing the use of our website without changing your browser settings, you give your consent to our use of cookies.

To learn more about cookies, how we use them and for what purposes, and how you can manage your browser settings to reject or control use of cookies, please read our Cookie Policy
triResolve QuickPort
Please fill in the form below and you will receive instructions on how to get up and running on triResolve QuickPort in just a few easy steps
Type in the text from the image below
Incorrect please try again
I have read and understood the Terms & Conditions
triResolve QuickPort
Thank you for your interest in triResolve QuickPort.

To begin the NDA download, please click here

You can get up and running in a few easy steps:

Step 1: Sign and return downloaded standard Confidentiality Agreement (NDA).
            Detailed instructions accompany the NDA.
Step 2: Our Service Management Team will contact you to provide access to our triResolve
            QuickPort website
and give you instructions on how to upload your data.
Step 3: Upload your portfolio data to the website (batch or manually).
            In your own preferred data format (converted by triResolve Service Management into standard format).
Step 4: Access your summary reconciliation results on the website as often as you or
            your counterparties provide new portfolio data.

With triResolve QuickPort, you can set up an STP process to reconcile your OTC derivatives portfolios with our large community of counterparties who currently use triResolve, including all of the global dealers. Once you are up and running you will experience all the benefits of triResolve QuickPort:

  • Timely and efficient submission of portfolio data assists with regulatory compliance for portfolio reconciliation requirements
  • Fully secure transmission of sensitive portfolio data
  • Centralized network of 250+ counterparties
  • Access to reconciliation summary results provides early warning of portfolio issues
  • Ability to automate file delivery
  • Free of charge

Please do not hesitate to contact TriOptima if you have any further questions, either by calling your regional TriOptima office or sending an e-mail to triresolvequickport@trioptima.com.

We look forward to working with you on triResolve QuickPort.

New York +1 646 744 0400
London +44 20 7382 2200
Stockholm +46 8 545 25 130
Singapore +65 6372 8181
Tokyo +81 3 6450 1350